{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:00:06Z","timestamp":1772802006219,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ymthe.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T05:30:23Z","timestamp":1497677423000},"page":"1743-1745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Progress toward Fulfilling the Potential of Immunomodulation in Childhood Neurodegeneration?"],"prefix":"10.1016","volume":"25","author":[{"given":"Jonathan D.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanth R.","family":"Nelvagal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.06.006_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.06.006_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/brain\/awt020","article-title":"Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"136","author":"Groh","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.06.006_bib3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/glia.22962","article-title":"Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease","volume":"64","author":"Groh","year":"2016","journal-title":"Glia"},{"issue":"10 Pt B","key":"10.1016\/j.ymthe.2017.06.006_bib4","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.06.006_bib5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/0883073813493665","article-title":"Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions","volume":"28","author":"Dolisca","year":"2013","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ymthe.2017.06.006_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ymthe.2017.06.006_bib7","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","article-title":"An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis","volume":"34","author":"Macauley","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.06.006_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.24815","article-title":"Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3)","volume":"80","author":"Aldrich","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2017.06.006_bib9","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.bbadis.2013.05.026","article-title":"Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)","volume":"1832","author":"Hawkins-Salsbury","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.06.006_bib10","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","article-title":"Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)","volume":"36","author":"Bosch","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.06.006_bib11","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.ymgme.2016.11.311","article-title":"Long-term safety and efficacy of intracerebroventricular enzyme replacement therapy with cerliponase alfa in children with CLN2 disease: interim results from an ongoing multicenter, multinational extension study","volume":"120","author":"Schulz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.06.006_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2017.06.006_bib13","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a\u00a0TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.06.006_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.23545","article-title":"Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis","volume":"71","author":"Macauley","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2017.06.006_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jnc.12385","article-title":"Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a\u00a0pro-inflammatory phenotype","volume":"127","author":"Xiong","year":"2013","journal-title":"J.\u00a0Neurochem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T01:03:01Z","timestamp":1533171781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617302678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1525001617302678"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.06.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress toward Fulfilling the Potential of Immunomodulation in Childhood Neurodegeneration?","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}